#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Becker's muscular dystrophy Waldenstrom's macroglobulinaemia refractory Dementia Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Desmoplastic small round cell tumour Antiphospholipid antibodies Breast angiosarcoma metastatic Acute myeloid leukaemia recurrent Porphyria non-acute Spinal cord injury cervical Rheumatoid arthritis Cardiac sarcoidosis Mantle cell lymphoma stage IV Cutaneous T-cell lymphoma refractory Von Willebrand's disease More trials…

    Learn about Rare Diseases

    Retinoblastoma Mantle cell lymphoma stage II – Diagnostics Ocular melanoma – Life with Disease Netherton’s syndrome – Trials in Disease Haemolytic uraemic syndrome – Treatment Alexander disease – Treatment Mantle cell lymphoma refractory – Trials in Disease Metachromatic leukodystrophy – Trials in Disease Rhabdomyosarcoma recurrent – Treatment Bronchiolitis obliterans syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Xylitol [99MTC]PSMA I&S 177LU-PSMA-I&T Balcinrenone Epinephrine Bitartrate Ligelizumab Mk-4830 Gemcitabine Enfuvirtide Cft1946 GSK5784283 Cefixime Etanercept Antipsychotics Amitriptyline Hydrochloride SODIUM DIHYDROGEN PHOSPHATE CAL101 Amantadine Hemisulfate RIMIDUCID Glasdegib More therapies…

    Learn about Your Condition

    Pulmonary vascular disorder Actinic cheilitis Transferrin decreased Thyroid disorder Autoimmune haemolytic anaemia Chronic lymphocytic leukaemia Retinal artery occlusion Synovial sarcoma metastatic Neurodegenerative disorder Retinal neovascularisation Testicular leiomyosarcoma Adenocarcinoma gastric Essential thrombocythaemia Immune-mediated myositis Death neonatal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary arterial hypertension

  • Study on Sotatercept for Improving Heart Function in Patients with Pulmonary Arterial Hypertension

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sotatercept
    The Netherlands

  • Study on the Safety and Tolerability of Treprostinil Sodium for Children with Pulmonary Arterial Hypertension

    Recruiting

    3 1 1
    Investigated Drugs:
    • Treprostinil Sodium
    Austria France Germany Hungary Slovakia Spain

  • Study on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Treprostinil
    Austria Czechia France Germany Hungary Italy +6

  • Study on Sotatercept for Children with Pulmonary Arterial Hypertension Receiving Standard Care

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Sotatercept
    France Germany The Netherlands Poland Spain

  • Vasopressin Versus Norepinephrine for Patients with Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Argipressin
    • Noradrenaline Tartrate
    France

  • A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Austria Belgium Czechia Denmark France Germany +9
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!